Kindstar Globalgene Technology Inc
HKEX:9960
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Kindstar Globalgene Technology Inc
Net Income (Common)
Kindstar Globalgene Technology Inc
Net Income (Common) Peer Comparison
603882
600763
300244
002044
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
K
|
Kindstar Globalgene Technology Inc
HKEX:9960
|
Net Income (Common)
¥41.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
G
|
Gushengtang Holdings Ltd
HKEX:2273
|
Net Income (Common)
¥252.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
Net Income (Common)
¥475.1m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Topchoice Medical Co Inc
SSE:600763
|
Net Income (Common)
¥504.7m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
17%
|
|
|
Dian Diagnostics Group Co Ltd
SZSE:300244
|
Net Income (Common)
¥170.4m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
7%
|
|
|
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
Net Income (Common)
¥386.2m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
See Also
What is Kindstar Globalgene Technology Inc's Net Income (Common)?
Net Income (Common)
41.3m
CNY
Based on the financial report for Dec 31, 2023, Kindstar Globalgene Technology Inc's Net Income (Common) amounts to 41.3m CNY.
What is Kindstar Globalgene Technology Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
-45%
Over the last year, the Net Income (Common) growth was -45%.
You don't have any saved screeners yet
